European Commission Delegation Visits Leiden Bio Science Park


Leiden Bio Science Park recently welcomed a high-level delegation from the European Commission during a visit to Johnson & Johnson, organised by Amoy Anderson, and the team.

The visit centred on the impact of international trade on the Life Sciences and Health sectors, both in the Netherlands and the wider EU. The morning began with a welcome by Wietske Veltman, Alderman for Economy, Knowledge, Health, and Sports for the Municipality of Leiden, followed by a presentation from Esther Peters, Director of Leiden Bio Science Park.

Key speakers included Anneke Sanders (Bristol Myers Squibb), Jan de Sonneville (Life Science Methods), Anouk De Vroey (Johnson & Johnson), and Professor Thomas Hankemeier (Leiden University), who emphasised the Park’s strong academic and translational capabilities.

In the afternoon, Rob van Overbeek from Kadans Science Partner led a tour introducing the delegation to three innovative companies: LeydenJar (battery innovation), Meatable (sustainable food production), and VarmX (therapies for bleeding disorders).

The visit highlighted the Park’s role in fostering innovation and international collaboration, reinforcing its mission to support science that serves society.


  • SpectaCell raises €6 million to accelerate drug development

    For the Leiden Bio Science Park, it is great to see SpectaCell connecting its technology with the biotech ecosystem here in Leiden. SpectaCell will combine its technology development and cell analysis in Ghent with further validation and application within the…

  • LUMC opens dedicated CAR-T department

    Leiden University Medical Center (LUMC) has opened a dedicated department for CAR-T cell therapy, bringing care, research and expertise in this rapidly developing field together in one place. The new department, officially opened on 24 September, marks another step in…